Evidence map›Paper›PMID 41427357›Full record

ArticlebioRxiv : the preprint server for biology2025

vir2vec: A Viral Genome-Wide Viral Embedding.

Simone Rancati, Pablo Arozarena Donelli, Giovanna Nicora, Laura Bergomi, Tommaso Mario Buonocore, Micheal Aaron Sy, Sakshi Pandey, Mattia Prosperi, Marco Salemi, Riccardo Bellazzi and 3 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Simone RancatiDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0009-0002-4405-1697
Pablo Arozarena DonelliDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0009-0002-3188-2504
Giovanna NicoraDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0000-0001-7007-0862
Laura BergomiDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0009-0006-0359-5128
Tommaso Mario BuonocoreDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0000-0002-2887-088X
Micheal Aaron SyDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, 2004 Mowry Road, Gainesville, FL 32610, United States.ORCID 0000-0001-9281-7592
Sakshi PandeyDepartment of Computer and Information Science and Engineering, University of Florida, 432 Newell Dr, Gainesville, FL 32611, United States.
Mattia ProsperiDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, 2004 Mowry Road, Gainesville, FL 32610, United States.ORCID 0000-0002-9021-5595
Marco SalemiEmerging Pathogens Institute, University of Florida, 2055 Mowry Road, Gainesville, FL 32610, United States.
Riccardo BellazziDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0000-0002-6974-9808
Christina BoucherDepartment of Computer and Information Science and Engineering, University of Florida, 432 Newell Dr, Gainesville, FL 32611, United States.
Enea ParimbelliDepartment of Electrical, Computer and Biomedical Engineering, University of Pavia, Via Adolfo Ferrata 5, Pavia, 27100, Italy.ORCID 0000-0003-0679-828X
Simone MariniDepartment of Epidemiology, College of Public Health and Health Professions, University of Florida, 2004 Mowry Road, Gainesville, FL 32610, United States.ORCID 0000-0002-5704-3533

Funding

A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)R01AI170187 · NIAID · UNIVERSITY OF FLORIDA · PI MARIA LUISA ALCAIDE, Deborah Lynne Jones · 2022 to 2026
$3.7M
NIAID NIH HHS R01 AI170187
6 · The paper itself

Abstract

Genomic language models (gLMs) have recently emerged as powerful numerical surrogates for DNA, but existing architectures are largely focused on human DNA or trained on limited viral references, and no dedicated benchmark currently exists for viral genome understanding. Here we introduce vir2vec, a 422-million-parameter, decoder-only gLM obtained by continual pretraining of Mistral-DNA on a rigorously curated pan-viral corpus of 565,747 complete genomes spanning 295 viral species. vir2vec operates on byte-pair-encoded DNA subwords and exposes fixed-length genome-level embeddings that are reused across tasks. Additionally, we present vGUE, a unified benchmark for viral representation learning. In vGUE, we precompute vir2vec embeddings and feed them to simple classifiers (logistic regression, support vector machines, random forests) trained under nested cross-validation, to quantify how well they capture biologically motivated axes of viral variation. Using this framework, vGUE assesses genomic viral prediction tasks across: (i) organism-level discrimination (virus vs non-virus genomes and reads), (ii) genome-wide evolutionary fingerprints (DNA vs RNA viruses, host-range prediction), (iii) intra-genus species separation (HIV-1 vs HIV-2), (iv) fine-grained variant and subtype typing (SARS-CoV-2 lineages), and (v) phenotypic context signal detection (HIV-1 brain vs plasma Tropism). vir2vec attains the highest balanced accuracy across seven out of eight heterogenous classification tasks consistently outperforming both a human-trained genomic foundation model and a viral-specific one. By coupling a pan-viral gLM with a standardized evaluation suite, vir2vec and vGUE provide an open foundation for future viral genomic models, surveillance tools, and discovery pipelines. vir2vec is released as a controlled-access resource with the understanding that it is designed for discriminative/classification embedding tasks, and not generative; responsible deployment of viral genomic models requires consideration of dual-use implications and appropriate ethical, governance oversight.

Identifiers

PMID41427357
PMCPMC12713144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.